Table 3. Demographic Characteristics of Study Participants

	Heat pattern (N=39)	No-Heat pattern (N=19)	p-value
Sex			0.04
Male	27 (69.2%)	7 (36.8%)	0.43
Female	12 (30.8%)	12 (63.2%)
Age (year)	28.0 [23.0 - 41.0]	30.0 [23.5 - 44.5]
Blood pressure (mmHg)			0.52
Systolic	119.8 ± 11.8	117.6 ± 13.4	0.44
Diastolic	78.7 ± 8.8	76.5 ± 12.3
Pulse (beats/min)	78.7 ± 11.1	87.3 ± 14.8	0.02
Body Temperature (°C)	36.5 [36.4 - 36.8]	36.7 [36.5 - 37.0]	0.68
Duration of rhinitis (yr)	10.0 [5.5 - 20.5]	15.0 [6.5 - 16.5]	0.99
Duration of current rhinitis symptoms (mo)	8.0 [3.0 - 18.0]	12.0 [6.0 - 42.0]
Accompanied by other allergic disease			0.30
Yes	13 (33.3%)	4 (21.1%)	0.51
No	26 (66.7%)	15 (78.9%)	0.27
TNSS	7.6 ± 1.7	7.1 ± 1.5	0.47
Mini-RQLQ	41.5 ± 13.1	38.7 ± 15.6
Nasal Endoscopy Index	6.0 [4.5 - 8.0]	6.0 [4.0 - 8.0]	0.82

Independent two-sample t-test, Wilcoxon's rank sum test for continuous variables, or chi-square test for dichotomous variables were used for statistical analysis and results are reported as mean ± standard deviation (SD), median [lower interquartile range - upper interquartile range], or number (percentile).
Abbreviations: RQLQ, rhinoconjunctivitis quality of life questionnaires; TNSS, total nasal symptom score